Nishimaki T, Kano K, Milgrom F
Int Arch Allergy Appl Immunol. 1979;60(1):115-9. doi: 10.1159/000232331.
By means of agglutination inhibition test, Paul-Bunnell (P-B) antigen was demonstrated in sera of patients with cancer (5%), lymphomas or leukemias (12.5%) and rheumatoid arthritis (RA) (1.4%) as well as in synovial fluids from RA patients (27%). In contrast, none of 124 normal human sera gave positive results. P-B antigen was also demonstrated in 3 of 12 perchloric acid extracts of cancer tissues and 2 of 11 saline extracts obtained at 100 degrees C from spleens of lymphoma-leukemia patients. Extracts of apparently normal tissues from 16 individuals gave negative results.
通过凝集抑制试验，在癌症患者（5%）、淋巴瘤或白血病患者（12.5%）以及类风湿关节炎（RA）患者（1.4%）的血清中，以及在RA患者的滑液中（27%）检测到了保罗 - 邦内尔（P - B）抗原。相比之下，124份正常人血清均未给出阳性结果。在12份癌组织的高氯酸提取物中有3份以及在11份从淋巴瘤 - 白血病患者脾脏在100℃获得的生理盐水提取物中有2份也检测到了P - B抗原。16名个体的看似正常组织的提取物结果为阴性。
